Document Detail


PXR antagonists and implication in drug metabolism.
MedLine Citation:
PMID:  23330542     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Adopted orphan nuclear receptor (NR), pregnane X receptor (PXR), plays a central role in the regulation of xeno- and endobiotic metabolism. Since the discovery of the functional role of PXR in 1998, there is evolving evidence for the role of PXR agonists in abrogating metabolic pathophysiology (e.g., cholestasis, hypercholesterolemia, and inflammation). However, more recently, it is clear that PXR is also an important mediator of adverse xeno- (e.g., enhances acetaminophen toxicity) and endobiotic (e.g., hepatic steatosis) metabolic phenotypes. Moreover, in cancer therapeutics, PXR activation can induce drug resistance, and there is growing evidence for tissue-specific enhancement of the malignant phenotype. Thus, in these instances, there may be a role for PXR antagonists. However, as opposed to the discovery efforts for PXR agonists, there are only a few antagonists described. The mode of action of these antagonists (e.g., sulforaphane) remains less clear. Our laboratory efforts have focused on this question. Since the original discovery of azoles analogs as PXR antagonists, we have preliminarily defined an important PXR antagonist pharmacophore and developed less-toxic PXR antagonists. In this review, we describe our published and unpublished findings on recent structure-function studies involving the azole chemical scaffold. Further work in the future is needed to fully define potent, more-selective PXR antagonists that may be useful in clinical application.
Authors:
Sridhar Mani; Wei Dou; Matthew R Redinbo
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Drug metabolism reviews     Volume:  45     ISSN:  1097-9883     ISO Abbreviation:  Drug Metab. Rev.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-21     Completed Date:  2013-07-16     Revised Date:  2014-03-26    
Medline Journal Info:
Nlm Unique ID:  0322067     Medline TA:  Drug Metab Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  60-72     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Azoles / pharmacokinetics,  pharmacology
Humans
Metabolic Detoxication, Drug
Receptors, Steroid / antagonists & inhibitors*,  metabolism*
Xenobiotics / pharmacokinetics,  pharmacology
Grant Support
ID/Acronym/Agency:
CA 127231/CA/NCI NIH HHS; P30 CA013330/CA/NCI NIH HHS; R01 CA127231/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Azoles; 0/Receptors, Steroid; 0/Xenobiotics; 0/pregnane X receptor
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver.
Next Document:  Nuclear receptors in herb-drug interactions.